Cough aerosol in healthy participants: Fundamental knowledge to optimize droplet-spread infectious respiratory disease management

BMC Pulmonary Medicine

Volumn 12, Issue , 2012, Pages

  Zayas, Gustavo ^a   Chiang, Ming C ^a   Wong, Eric ^b   MacDonald, Fred ^c   Lange, Carlos F ^b   Senthilselvan, Ambikaipakan ^b   King, Malcolm ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Edmonton General Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AEROSOL; AIRBORNE INFECTION; ARTICLE; BODY HEIGHT; BODY WEIGHT; CONTROLLED STUDY; COUGHING; DISEASE TRANSMISSION; FEMALE; HUMAN; INFLUENZA VIRUS A H1N1; KNOWLEDGE; LASER DIFFRACTION; MALE; NORMAL HUMAN; PANDEMIC INFLUENZA; PARTICIPANT OBSERVATION; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT INFECTION; STATISTICAL SIGNIFICANCE; ANALYSIS OF VARIANCE; INFECTION CONTROL; MIDDLE AGED; PARTICLE SIZE; THEORETICAL MODEL;

ADULT; AEROSOLS; ANALYSIS OF VARIANCE; COMMUNICABLE DISEASE CONTROL; COUGH; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PARTICLE SIZE; RESPIRATORY TRACT INFECTIONS; YOUNG ADULT;

EID: 84858592033     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-12-11     Document Type: Article

References (60)

1. WHO Influenza pandemic preparedness plan. The role of WHO and guidelines for national or regional planning. 1999, Geneva: World Health Organization, WHO.
2. WHO Anti-Tuberculosis Drug Resistance in the World. Report N° 2: Prevalence and Trends. 2000, Geneva: The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, WHO.
3. WHO Global Plan to Stop TB, Chapter 1, p 27, Stop TB Partnership. 2001, Geneva: WHO, WHO.
4. WHO Infectious disease report. 2002, Geneva: World Health Organization, WHO.
5. WHO Global Defense against the Infectious Disease Threat. 2003, Geneva: World Health Organization, Kindhauser MK, WHO.
6. WHO Fact Sheet N° 104. 2010, Geneva: World Health Organization, WHO.
7. Cecil Medicine. 2008, Philadelphia: Saunders Elsevier, Goldman L, Ausiello D, 23.
8. Kian FC, Widdicombe JG. Cough. Murray and Nadel's Textbook of Respiratory Medicine 2010, Philadelphia: Saunders: Elsevier, Mason RJ, Broaddus VC, Martin TR, King TE, Schraufnagel DE, Murray JF, Nadel JA.
9. Taliercio RM, Culver DA. Cough. Cleveland Clinic: Current Clinical Medicine 2010, Philadelphia: Saunders: Elsevier, Carey WD, 2.
10. Morse SS, Garwin RL, Olsiewski PJ. Next flu pandemic: what to do until the vaccine Arrives?. Science 2006, 314(5801):929. 10.1126/science.1135823, 17095681.
11. WHO Press Release, Cases of Severe Respiratory Illness May Spread To Hospital. 2003, Geneva: World Health Organization, WHO.
12. Breytenback JH. Avian Influenza in South Asia, is there a solution?. Intervet International 2005, , http://thepoultrysite.com
13. Centre for Infectious Disease Prevention and Control and Health Canada Cluster of severe acute respiratory syndrome cases among protected healthcare workers. Ottawa: WHO, Geneva, Switzerland; Immunization and Respiratory Infections Division, Centre for Infectious Disease Prevention and Control, Health Canada, Ottawa, Canada, and CDC SARS Investigation Team 2003, 29(08). Centre for Infectious Disease Prevention and Control and Health Canada.
14. Centers for Disease Control and Prevention Use of Quarantine to Prevent Transmission of Severe Acute Respiratory Syndrome - Taiwan, 2003. JAMA 2003, 52:680-683. 290, (No. 8), reprinted from MMWR, Centers for Disease Control and Prevention.
15. WHO Avian influenza ("bird flu") and the significance of its transmission to humans. 2004, Geneva: World Health Organization, WHO.
16. WHO Avian influenza: assessing the pandemic threat. 2005, Geneva: WHO/CDS/2005.29, WHO.
17. Salgado C, et al. Influenza in the acute hospital setting. Lancet Infect Dis 2002, 2:145-155. 10.1016/S1473-3099(02)00221-9, 11944184.
18. Buxton Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis 2003, 37:1094-1101. 10.1086/378292, 14523774.
19. Garner J. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996, 17:53-80. 10.1086/647190, 8789689.
20. Stott DJ, Kerr G, Carman WF. Nosocomial transmission of influenza. Occup Med (Lond) 2002, 52:249-253.
21. Goldmann D. Transmission of viral respiratory infections in the home. Pediatr Infect Dis J 2000, 19:S97-S102. 10.1097/00006454-200010001-00002, 11052396.
22. WHO Avian influenza, including influenza A (H5N1), in humans. 2007, Geneva: WHO interim infection control guidelines for health-care facilities, WHO.
23. WHO Influenza-like illness in the United States and Mexico. 2009, Geneva: World Health Organization, WHO.
24. Morice AH, Fontana GA, Belvisi MG, Birring SS, Chung KF, Dicpinigaitis PV, Kastelik JA, McGarveye LP, Smith JA, Tatar M, Widdicomb J. ERS guideline on the assessment of cough. Eur Respir J 2007, 29:1256-1276. 10.1183/09031936.00101006, 17540788.
25. Hertzberg J. Flow Field of a Human Cough. American Physical Society, 58th Annual Meeting of the Division of Fluid Dynamics, November 20-22, 2005 abstract #HA.001.
26. Gupta JK, Lin CH, Chen Q. Flow dynamics and characterization of a cough. Indoor Air 2009, 19:517-525. 10.1111/j.1600-0668.2009.00619.x, 19840145.
27. Duguid J. The numbers and sites of origin of the droplets expelled during respiratory activities. Edinburgh Med 1945, 52:385.
28. Xie X, Li Y, Sun H, Liu L. Exhaled droplets due to talking and coughing. J R Soc Interface 2009, 6(Suppl 6):S703-S714. 2843952, 19812073.
29. Fairchild CI, Stampfer JF. Particle Concentration in Exhaled Breath. Am Ind Hyg Assoc J 1987, 48(11):948. 10.1080/15298668791385868, 3425555.
30. Papineni RS, Rosenthal FS. The Size Distribution of Droplets in the Exhaled Breath of Healthy Human Subjects. J Aerosol Med 1997, 10(2):105-116. 10.1089/jam.1997.10.105, 10168531.
31. Edwards DA, Man JC, Brand P, Katstra JP, Sommerer K, Stone HA, Nardell E, Scheuch G. Inhaling to mitigate exhaled bioaerosols. PNAS 2004, 101(50):17383-17388. 10.1073/pnas.0408159101, 536048, 15583121.
32. Yang S, Lee GW, Chen CM, Wu CC, Yu KP. The size and concentration of droplets generated by coughing in human subjects. J Aerosol Med 2007, 20(4):484-494. 10.1089/jam.2007.0610, 18158720.
33. Morawska L, Johnson GR, Ristovski ZD, Hargreaves M, Mengersen K, Corbett S, Chao CYH, Li Y, Katoshevski D. Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities. J Aerosol Sci 2009, 40(3):256-269.
34. Schwarz K, Biller H, Windt H, Koch W, Hohlfeld JM. Characterization of Exhaled Particles from the Healthy Human Lung. A Systematic Analysis in Relation to Pulmonary Function Variables. J Aerosol Med Pulm Drug Deliv 2010, 23(6):371-379. 10.1089/jamp.2009.0809, 20500095.
35. Hersen G, Moularat S, Robine E, Hehin E, Corbert S, Vebret A, Freymuth F. Impact of Health on Particle Size of Exhaled Respiratory Aerosols: Case-control Study. Clean 2008, 36(7):572-577.
36. Chao CYH, Wan MP, Morawska L, Johnson GR, Ristovski ZD, Hargreaves M, Mengersen K, Corbett S, Li Y, Xie X, Katoshevski D. Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci 2009, 40(2):122-133.
37. Tang JW, Liebner TJ, Craven BA, Settles GS. A schlieren optical study of the human cough with and without wearing masks for aerosol infection control. J R Soc Interface 2009, 6(Suppl 6):S727-S736. 2843945, 19815575.
38. Royston PA. A pocket-calculator algorithm for the Shapiro-Francia test for normality: an application to Medicine. Stat Med 1993, 12(2):181-184. 10.1002/sim.4780120209, 8446812.
39. King M. Rheological requirements for optimal clearance of secretions: ciliary transport versus cough. Eur J Respir Dis 1980, 61(Suppl. 110):39-42.
40. King M. Role of mucus viscoelasticity in cough clearance. Biorheology 1987, 24:589-597.
41. ISO International Organization for Standardization ISO13320:2009(E):Particles size analysis -- Laser diffraction methods. 2009, Geneva: International Organization for Standardization, 1, ISO International Organization for Standardization., http://www.iso.ch
42. Berge D, Pearce A. Physics in Anesthesia: the fiberoptic intubating laryngoscope. Updating in Anesthesia 2005, (19).
43. Caroline Reid Spectroscopic methods for medical diagnosis at terahertz wavelength. PhD Thesis 2009, Dept of Medical Physics and Bioengineering, University College London, Caroline Reid.
44. Zayas G, Dimitry J, Zayas A, O'Brien D, King M. A new paradigm in respiratory hygiene: increasing the cohesivity of airway secretions to improve cough interaction and reduce aerosol dispersion. BMC Pulm Med 2005, 5:11. 10.1186/1471-2466-5-11, 1208914, 16138926., http://www.biomedcentral.com/1471-2466/5/11
45. Zayas G, Valle JC, Alonso M, Alfaro H, Vega D, Bonilla G, Reyes M, King M. A new paradigm in respiratory hygiene: modulating respiratory secretions to contain cough bioaerosol without affecting mucus clearance. BMC Pulm Med 2007, 7:11. 10.1186/1471-2466-7-11, 1988832, 17697323.
46. Lowen AC, Mubareka S, Tumpey TM, García-Sastre A, Palese P. The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci USA 2006, 103(26):9988-9992. Epub 2006 Jun 19, 10.1073/pnas.0604157103, 1502566, 16785447.
47. Mubareka S, Lowen AC, Steel J, Coates AL, García-Sastre A, Palese P. Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis 2009, 199(6):858-865. 10.1086/597073, 19434931.
48. Zayas JG. Tracheobronchial mucus rheology in lung cancer. M Sc thesis 1991, University of Alberta, Department of Medicine.
49. Johnson GR, Morawska L, Ristovski ZD, Hargreaves M, Mengersen K, Chao CYH, Wan MP, Li Y, Xie X, Katoshevski D, Corbet S. Modality of human expired aerosol size distributions. J Aerosol Sci 2011, 42(12):839-851.
50. King M, Brock G, Lundell C. Clearance of mucus by simulated cough. J Appl Physiol 1985, 58:1776-1782.
51. King M, Wight A, DeSanctis GT, et al. Mucus hypersecretion and viscoelastic changes in cigarette-smoking dogs. Exp Lung Res 1989, 15:375-389. 10.3109/01902148909087866, 2743951.
52. Zayas JG, Man GC, King M. Tracheal mucus rheology in patients undergoing diagnostic bronchoscopy. Interrelations with smoking and cancer. Am Rev Respir Dis 1990, 141(5 Pt 1):1107-1113.
53. Zayas JG, Rubin BK, York EL, Lien DC, King M. Bronchial mucus properties in lung cancer: relationship with site of lesion. Can Respir J 1999, 6(3):246-252.
54. Irwin RS, Boulet LP, Cloutier MM, Fuller R, Gold PM, Hoffstein V, Ing AJ, McCool FD, O'Byrne P, Poe RH, Prakash UB, Pratter MR, Rubin BK. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Phycisians. Chest 1998, 114:133-181.
55. The Council of Canadian Academies Influenza transmission and the role of personal protective respiratory equipment: an assessment of the evidence. Expert Panel on Influenza and Personal Protective Respiratory Equipment 2008, Ottawa: The Council of Canadian Academies, The Council of Canadian Academies.
56. Tellier R. Review of aerosol transmission of influenza A virus. Emerg Infect Dis 2006, 12(11):1657-1662. 10.3201/eid1211.060426, 17283614.
57. Tellier R. Aerosol: Transmission of Influenza A virus: a review of new studies. J R Soc Interface 2009, 6(Suppl 6):S738-S790.
58. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beigns. Lancet Infect Dis 2007, 7:257-265. 10.1016/S1473-3099(07)70029-4, 17376383.
59. Sullivan S, Jacobson R, Dowdle W, Poland G. 2009 H1N1 Influenza. Mayo Clin Proc 2010, 85(1):64-76. 10.4065/mcp.2009.0588, 2800287, 20007905.
60. Health Canada Learning Lessons from SARS. Renewal of Public Health in Canada. A report of the National Advisory Committee on SARS and Public Health 2003, Health Canada.